Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erdosteine in Stable Chronic Bronchitis Associated With COPD
NCT00338507Phase 2Completed
- Sponsor
- Adams Respiratory Therapeutics
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of erdosteine in chronic bronchitis (CB) (3 arms), sponsored by Adams Respiratory Therapeutics. Primary endpoint: Change from baseline in Cough Severity Score at 4 weeks. Started Mar 2006; status: completed.
02
Drugs
erdosteine
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT00338507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338507.